Skip to content

Clinical trials

Phase 3 Schizophrenia trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Status: Unknown status Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20062
20082
20101
20113
20131
20142
20151
20192
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beersheva Mental Health Center2
Sheba Medical Center2
Beer Yaakov - Ness Ziona Mental Health Center1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
Corporation de Recherche en Neuropsycho Pharmacologie de Quebec1
Hospital de Clinicas de Porto Alegre1
Lee's Pharmaceutical Limited1
National Taiwan University Hospital1
Philipps University Marburg1
Shanghai Mental Health Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia19
Psychotic Disorders5
Anxiety Disorders1
Bipolar Disorder1
Cognition Disorders1
Cognitive Dysfunction1
Hyperprolactinemia1
Inflammation1
Neurobehavioral Manifestations1
Psychomotor Agitation1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.